Literature DB >> 33881052

A dual-catalytic nanoreactor for synergistic chemodynamic-starvation therapy toward tumor metastasis suppression.

Huiwen Zhang1, Fei Lu1, Wei Pan1, Yegang Ge1, Bingjie Cui1, Shaohua Gong1, Na Li1, Bo Tang1.   

Abstract

Tumor metastasis is extremely deadly for cancer patients and developing effective treatments for deep metastatic tumors remains a major challenge. In this study, we demonstrated a dual-catalytic nanoreactor for tumor metastasis suppression by synergistic Fenton reaction activated chemodynamic therapy (CDT) and glucose oxidase (GOx) initiated starvation therapy. GOx on the surface of hollow mesoporous silica nanoparticles can catalyze the decomposition of intratumoral glucose to generate gluconic acid and H2O2, while Fe3O4 nanoparticles as a Fenton reaction catalyst can in situ catalyze H2O2 to produce highly toxic hydroxyl radicals (˙OH). The oxygen-carrying perfluorohexane (PFC) in the hole of the hollow structures can alleviate the hypoxic environment and promote dual-catalytic reactions. After being disguised by the cancer cell membrane, the delivery efficiency and biological safety of the nanoreactor were effectively improved. The nanoreactor can realize sequential glucose depletion and ˙OH aggregation, which effectively suppress tumor metastasis with negligible side effects.

Entities:  

Year:  2021        PMID: 33881052     DOI: 10.1039/d1bm00240f

Source DB:  PubMed          Journal:  Biomater Sci        ISSN: 2047-4830            Impact factor:   6.843


  2 in total

Review 1.  Glucose Metabolism Intervention-Facilitated Nanomedicine Therapy.

Authors:  Zhiyan Li; Xianghui Li; Shichao Ai; Song Liu; Wenxian Guan
Journal:  Int J Nanomedicine       Date:  2022-06-17

Review 2.  Research Progress on Improving the Efficiency of CDT by Exacerbating Tumor Acidification.

Authors:  Wenting Chen; Jinxi Liu; Caiyun Zheng; Que Bai; Qian Gao; Yanni Zhang; Kai Dong; Tingli Lu
Journal:  Int J Nanomedicine       Date:  2022-06-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.